Abstract: A liquid crystal display (LCD) device having a slim border, a high reliability and a better residual-image characteristic is described. The LCD device includes a pair of substrates, liquid crystal alignment films, a sealing part disposed on surfaces of the liquid crystal alignment films, and a liquid crystal layer containing liquid crystal molecules. The liquid crystal alignment films include a polymer (P) having in its main chain a moiety (1) or (2) described below. The moiety (1) is an alkylene chain having 3 or more carbon atoms. The moiety (2) has a structure obtained by inserting one or more of —CO—, —O—, —NH— and —Si(R1)2— between carbon atoms of an alkylene chain having 3 or more carbon atoms, wherein R1 is a monovalent hydrocarbon group having 1 to 12 carbon atoms.

Abstract: The present invention relates to a multilayer coating in which a plurality of photocurable resin cured films are layered on a substrate, wherein at least two adjacent layers comprise the same hindered phenol-type antioxidant. The multilayer coating can be applied onto a substrate, such as glass fibers, vinyl chloride sheets, polycarbonate sheets, glass plates, polyethylene films, wood, acrylic sheets, metal plates, and the like.

Abstract: A thermosetting resin composition comprising a polymer having a methylglycidyl group and an ultraviolet absorbent. This thermosetting resin composition has excellent storage stability and forms an antihalation film which can effectively suppress diffused reflection light from a foundation substrate in an exposure step for forming a color filter or microlens in a solid-state imaging device, has high heat resistance and does not have a rough surface even when it is subjected to dry etching.

Abstract: Provided is a liquid curing resin composition exhibiting excellent adhesion to PET-PET, MS-PET and the like, having excellent processability, heat resistance and water resistance, and having a high-cure rate. A liquid curing resin composition containing the following components (A) and (B): (A) 30 to 70 wt. % of a urethane (meth)acrylate having a number-average molecular weight of from 10000 to 40000, and (B) 30 to 60 wt. % of an ethylenically unsaturated monomer having a glass transition point, in the form of a homopolymer, of 60° C. or greater.

Abstract: A radiation-curable resin composition for adhesives comprising (A) a bisphenol-type epoxy (meth)acrylate having a hydroxyl group, (B) a polyfunctional (meth)acrylate having an aliphatic cyclic structure or an aromatic cyclic structure other than the component (A), and (C) a photoinitiator, wherein the content of the component (A) and the content of the component (B) in the composition are respectively 30 wt % or more. The radiation-curable resin composition for adhesives of the present invention exhibits excellent adhesion to silver, silicon compound, and aluminum, superior moisture-heat resistance, and fast curability, especially at the edge of the disk, and therefore is very useful in the manufacture of optical disks in comparison with conventional adhesives.

Abstract: The present invention relates to a multilayer coating in which a plurality of photocurable resin cured films are layered on a substrate, wherein at least two adjacent layers comprise the same hindered phenol-type antioxidant.

Abstract: A liquid radiation curable resin composition comprising a polydimethylsiloxane compound which has (i) at least two urethane bonds in one molecule, (ii) an unreactive organic group at at least one of the ends of the molecule, and (iii) a radical curable ethylenically unsaturated group at the other end of the molecule. The resin composition exhibits superior shelf life in a liquid state and produces cured products having slippery surface. It is suitable as a coating material for optical fibers.

Abstract: DL- or L-Threo-3-(3,4-dihydroxyphenyl)-N-methyl-serine which may also be termed as DL- or L-threo-adrenalinecarboxylic acid are now provided, which are new compounds useful for therapeutic treatment of Parkinson's disease and mental depression disease.

Abstract: A 1,3-dithiole derivative having the formula: ##STR1## wherein each of R.sup.1 and R.sup.2 is a substituted or unsubstituted alkyl, cycloalkyl, lower alkenyl, lower alkynyl, aryl or aralkyl group or R.sup.1 and R.sup.2 together form a substituted or unsubstituted alkylene or alkenylene group having from 3 to 6 carbon atoms, which may contain a cycloalkylene group, an o-phenylene group or a hetero atom selected from the group consisting of an oxygen atom, a sulfur atom and a nitrogen atom which may have a substituent, and Q is an acid residue useful for the treatment of liver diseases.

Abstract: A 1,3-dithiol-2-ylidene derivative of the formula: ##STR1## wherein each of R and R.sup.1 which may be the same or different, is a lower alkyl group, a lower alkenyl group, a cycloalkyl group, a lower alkoxyalkyl group, or a substituted or unsubstituted aryl, aralkyl or heterocyclic group, or R and R.sup.1 together form a substituted or unsubstituted ethylene or trimethylene group.

Abstract: An .alpha.-tocopheryl 5-substituted picolinate of the formula ##STR1## wherein R represents an alkyl group which may have a substituent, a lower alkenyl group, a phenyl(lower alkyl) group, or a phenyl group which may have a substituent, and Q represents a methylene group or an oxygen or sulfur atom, or a pharmaceutically acceptable acid addition salt thereof. This compound can be produced by reacting a substituted picolinic acid of the formula ##STR2## wherein R and Q are as defined above, or its reactive derivative with .alpha.-tocopherol of the formula ##STR3## and as required, contacting the resulting compound with a pharmaceuticlly acceptable acid. A pharmaceutical composition comprising said compound as an active ingredient is useful for the treatment of hypertension.

Abstract: An N-acyl-3-[4-(benzoylalkyl)piperazin-1-yl]-sydnonimine compound represented by the following formula ##STR1## wherein R.sup.1 represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms,R.sup.2 represents a lower alkyl group,a lower alkoxy group or a phenyl group, andn represents zero or an integer of 1 to 10,and its acid addition salt. The above sydnonimine compounds are useful for the treatment of troubles of the circulatory system and can be produced by contacting a 3-[4-(benzoylalkyl)-piperazin-1-yl]sydnonimine compound represented by the following formula ##STR2## wherein R.sup.1 and n are as defined, with a carboxylic acid represented by the following formulaR.sup.2 COOHwherein R.sup.2 is as defined.

Abstract: A 3-[4-(benzoylalkyl)piperazin-1-yl]sydnonimine compound represented by the following formula ##STR1## wherein R represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, and n represents zero or an integer of 1 to 10,and its acid addition salt. The above sydnonimine compounds are useful for the treatment of troubles of the circulatory system and can be produced by contacting a 4-(benzoylalkyl)-1-(N-nitrosocyanomethylamino)piperazine represented by the following formula ##STR2## wherein R and n are as defined, with an acid.

Abstract: A new compound is produced which has the general formula: ##STR1## wherein R represents hydrogen atom or a lower alkyl group and which exhibits an immunopotentiating activity. This new compound as well as its pharmaceutically acceptable salts and hydrates are useful for immunotherapy and treatment of immune diseases and disorders in living animals including human beings. The new compound can be produced by reduction of a hydroxyterephthalic acid alkyl ester or by esterification of the corresponding 3-hydroxy-4-(hydroxymethyl)-benzoic acid.